A recent discussion in the aesthetic community highlights potential complications from prior injectable treatments when considering facelift surgery. Dr. L. Mike Nayak’s viral video showcased contrasting surgical conditions in patients with different histories of fillers, suggesting that certain injectables like Sculptra can create problematic tissue changes. While not every patient will face complications, many surgeons express concern about issues such as scarring and fat loss from previous treatments.
Surveys indicate that a significant percentage of surgeons find that injectables can lead to difficulties during facelifts, with 82% noting substantial scarring linked to Sculptra and other biostimulators. Despite manufacturers’ assurances about the safety of their products, many practitioners remain wary of the long-term effects on surgical outcomes. The debate underscores the need for careful consideration of non-surgical options and their potential impact on future procedures. As aesthetic medicine continues to evolve, the relationship between injectables and surgical interventions remains a critical topic for both patients and surgeons.
You Might Be Interested In:
